Poly(D,L-lactide) nanocapsules containing non-steroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administration

Pharm Res. 1995 Oct;12(10):1545-7. doi: 10.1023/a:1016208125979.

Authors

S S Guterres¹, H Fessi, G Barratt, F Puisieux, J P Devissaguet

Affiliation

¹ Laboratoire de Pharmacie Galénique et Biopharmacie, URA 1218, Faculté de Pharmacie, Université Paris XI, Châtenay-Malabry, France.

PMID: 8584497
DOI: 10.1023/a:1016208125979

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Animals
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Capsules
Diclofenac / administration & dosage
Diclofenac / adverse effects*
Drug Carriers
Indomethacin / administration & dosage
Indomethacin / adverse effects*
Infusions, Intravenous
Intestine, Small / drug effects*
Male
Polyesters*
Rats
Rats, Wistar
Stomach / drug effects*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Capsules
Drug Carriers
Polyesters
Diclofenac
poly(lactide)
Indomethacin